GSK-MKI113006

Study Sponsor: GSK

Study Title

A Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice Daily compared with Placebo for 24 Weeks in Adult Subjects with Chronic Obstructive Pulmonary Disease (COPD).

Medicine or Vaccine (generic name)

losmapimod

Sponsor Identification Number

MKI113006

Trial Registry Identification Number(#'s)

NCT01218126 2010-019695-76

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113006

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01218126

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-019695-76

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

GSK has divested the asset and the associated data to Fulcrum Therapeutics, and is no longer able to share the data associated with these studies

Date Added to this Site

October 2016